Arms

Arm	Treatment	Background	Randomized	Analyzed	Completed treatment
A1	Dulaglutide flexible dose injection once weekly Dulaglutide (observation group)	none; lifestyle: standard		48
A2	Liraglutide 1.2 mg subcutaneous once daily Liraglutide (control group)	none; lifestyle: standard		48

Baseline characteristics

As printed in the trial reports or registry, per arm or for the whole trial.

Characteristic	Statistic	Dulaglutide flexible dose injection once weekly A1	Liraglutide 1.2 mg subcutaneous once daily A2	Whole trial ALL
age	max (years)			69
age	mean (years)			46.14
age	min (years)			23
age	sd (years)			5.78
bmi	max (kg/m2)			29.34
bmi	mean (kg/m2)			22.62
bmi	min (kg/m2)			18.31
bmi	sd (kg/m2)			3.71
diabetes duration	max (years)			12
diabetes duration	mean (years)			5.73
diabetes duration	min (years)			1
diabetes duration	sd (years)			0.92
female	n			96
hba1c	mean (percent)	7.89	7.92
hba1c	sd (percent)	0.93	0.96

12 adjudicated result lines, grouped by outcome. Open an outcome to see its values.

HbA1c change (2 lines; O01)

Week	Arm	Statistic	Estimate	SE or SD	95% CI	Events / N	Detail
24	A1	final	5.67 percent	0.71		48	not stated; other; R0016372:Table 1
24	A2	final	6.74 percent	0.82		48	not stated; other; R0016372:Table 1

Level 2 or 3 hypoglycemia (participants) (2 lines; O04)

Week	Arm	Statistic	Estimate	SE or SD	95% CI	Events / N	Detail
	A1	events				1 / 48	not stated; other; R0016372:Table 4
	A2	events				2 / 48	not stated; other; R0016372:Table 4

Discontinuation due to adverse events (2 lines; O26)

Week	Arm	Statistic	Estimate	SE or SD	95% CI	Events / N	Detail
	A1	events				0 / 48	not stated; other; R0016372:Results
	A2	events				0 / 48	not stated; other; R0016372:Results

Nausea (2 lines; O27A)

Week	Arm	Statistic	Estimate	SE or SD	95% CI	Events / N	Detail
	A1	events				0 / 48	not stated; other; nausea and vomiting; R0016372:Table 4
	A2	events				2 / 48	not stated; other; nausea and vomiting; R0016372:Table 4

Discontinuation due to gastrointestinal adverse events (2 lines; O27E)

Week	Arm	Statistic	Estimate	SE or SD	95% CI	Events / N	Detail
	A1	events				0 / 48	not stated; other; R0016372:Results
	A2	events				0 / 48	not stated; other; R0016372:Results

Gallbladder and biliary disease (2 lines; O28)

Week	Arm	Statistic	Estimate	SE or SD	95% CI	Events / N	Detail
	A1	events				0 / 48	not stated; other; cholecystitis; R0016372:Table 4
	A2	events				2 / 48	not stated; other; cholecystitis; R0016372:Table 4